$HJLI Hancock Jaffe Laboratories, Inc. Insider Trading
Get free email notifications about insider trading in Hancock Jaffe Laboratories, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Hancock Jaffe Laboratories, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Hancock Jaffe Laboratories, Inc. for free.
IRS Number: 330936180
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: HJLI
Company Address: 70 DOPPLER IRVINE 92618
Phone number: (949) 261-2900
Hancock Jaffe Laboratories, Inc. is a development stage medical device company, which develops tissue based solutions that are designed to be life sustaining or life enhancing for patients with cardiovascular disease, and peripheral arterial and venous disease. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve. The company was founded by Norman Jaffe on December 22, 1999 and is headquartered in Irvine, CA.
Hancock Jaffe Laboratories, Inc. Insiders Active In Last 3 Months
Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
---|---|---|---|---|---|---|---|
BERMAN ROBERT ANDREW | Chief Executive Officer | 21,740 | 0 | shares bought: 21,740 / shares sold: 0 | BUY | Feb 22 2021 | 2 months ago |
Duhay Francis | Director | 107,228 | 0 | shares bought: 91,683 / shares sold: 0 | STRONG BUY | Feb 22 2021 | 2 months ago |
Glickman Marc H. | SVP & CMO | 0 | 0 | Feb 22 2021 | 2 months ago | ||
Glynn Craig | Chief Financial Officer | 0 | 0 | Feb 23 2021 | 2 months ago | ||
Gray Robert | Director | 78,250 | 0 | shares bought: 62,500 / shares sold: 0 | BUY | Feb 22 2021 | 2 months ago |
Jenusaitis Matthew | Director | 62,500 | 0 | shares bought: 62,500 / shares sold: 0 | BUY | Feb 22 2021 | 2 months ago |
Shrivastava Sanjay | Director | 97,500 | 0 | shares bought: 91,683 / shares sold: 0 | STRONG BUY | Feb 22 2021 | 2 months ago |
View all Hancock Jaffe Laboratories, Inc. insiders.
Hancock Jaffe Laboratories, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | HJLI | Hancock Jaffe Labo ... | Glynn Craig | Chief Financial Off ... | Option Exercise | A | 8.20 | 324,000 | 2,656,800 | 324 | |
Feb 23 2021 | HJLI | Hancock Jaffe Labo ... | Glynn Craig | Chief Financial Off ... | Option Exercise | A | 10.00 | 4,000 | 40,000 | 4,000 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | Duhay Francis | Director | Option Exercise | A | 8.20 | 5,673 | 46,519 | 5,673 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | Jenusaitis Matthew | Director | Option Exercise | A | 8.20 | 5,673 | 46,519 | 5,673 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | Shrivastava Sanjay | Director | Option Exercise | A | 8.20 | 5,673 | 46,519 | 5,673 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | BERMAN ROBERT ANDREW | Chief Executive Off ... | Option Exercise | A | 8.20 | 838,000 | 6,871,600 | 838,000 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | Gray Robert | Director | Option Exercise | A | 8.20 | 5,673 | 46,519 | 5,673 | |
Feb 22 2021 | HJLI | Hancock Jaffe Labo ... | Glickman Marc H. | SVP & CMO | Option Exercise | A | 8.20 | 406,000 | 3,329,200 | 406,000 | |
Oct 21 2020 | HJLI | Hancock Jaffe Labo ... | Jenusaitis Matthew | Director | Option Exercise | A | 0.40 | 100,000 | 40,000 | 100,000 | |
Oct 21 2020 | HJLI | Hancock Jaffe Labo ... | Jenusaitis Matthew | Director | Option Exercise | A | 2.00 | 60,000 | 120,000 | 60,000 | |
Oct 21 2020 | HJLI | Hancock Jaffe Labo ... | Jenusaitis Matthew | Director | Option Exercise | A | 0.00 | 78,125 | 0 | 78,125 | |
Oct 21 2020 | HJLI | Hancock Jaffe Labo ... | Jenusaitis Matthew | Director | Grant | A | 0.00 | 62,500 | 0 | 62,500 | 0 to 62.5 K |
Oct 01 2020 | HJLI | Hancock Jaffe Labo ... | Biodyne Holding, S.A. | Sell | S | 0.38 | 75,000 | 28,500 | 1,405,433 | 1.5 M to 1.4 M (-5.07 %) | |
Oct 01 2020 | HJLI | Hancock Jaffe Labo ... | Biodyne Holding, S.A. | Sell | S | 0.27 | 75,000 | 20,250 | 1,480,433 | 1.6 M to 1.5 M (-4.82 %) | |
Oct 01 2020 | HJLI | Hancock Jaffe Labo ... | Biodyne Holding, S.A. | Sell | S | 0.30 | 50,000 | 15,000 | 1,555,433 | 1.6 M to 1.6 M (-3.11 %) |
View all Hancock Jaffe Laboratories, Inc. insider transactions.